Transfusion-dependent Anemia
📧 Sign up to get email alerts when something new happens for Transfusion-dependent Anemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-11-14FDA Approved: DEFERASIROX — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for deferasirox submitted by Sun Pharmaceutical Industries, Inc., approving changes to the product l…
-
FDA approval · 2021-03-17FDA Approved: DEFERASOROX — Original Application (Novadoz Pharmaceuticals LLC)
The FDA granted approval for the original ANDA application of Deferasorox (deferasirox) by Novadoz Pharmaceuticals LLC as a generic product.…
-
FDA approval · 2019-05-24FDA Approved: EXJADE — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Exjade (deferasirox) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2015-03-30FDA Approved: JADENU — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved JADENU (deferasirox) through an Original Application for the treatment of chronic iron overload due to blood transfusions; the …